Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)

Carbonatix Pre-Player Loader

Audio By Carbonatix

WEST CHESTER, Pa.--(BUSINESS WIRE)--Oct 10, 2025--

Molecular Targeting Technologies, Inc. (MTTI) has filed a formal legal complaint in the Court of Common Pleas for Chester County, Pennsylvania concerning the unauthorized use of its EB-TRT technology by Dr. Xiaoyuan (Shawn) Chen, a former consultant who had previously worked with the company in a professional capacity pursuant to a consulting services agreement.

During his engagement with MTTI, Dr. Chen was granted access to proprietary EB-TRT technology under strict confidentiality. MTTI subsequently discovered that Dr. Chen committed multiple breaches of his consulting services agreement by, among other things, co-founding a new enterprise, which is utilizing key aspects of MTTI’s protected intellectual property without authorization or license to start the company.

“MTTI has always been committed to innovation and the lawful protection of our intellectual property. MTTI obtained the commercial license of this technology from National Institutes of Health of United States of America,” said Dr. Chris Pak, President & CEO at MTTI. “We view this matter with the utmost seriousness and have taken appropriate legal steps to safeguard our technology and the interests of our stakeholders.”

The legal complaint alleges that Dr. Chen acted in direct violation of multiple contractual obligations arising from his prior role as a consultant for MTTI. In addition to this filing, MTTI is conducting broader investigation and considering legal actions in other jurisdictions.

At this time, MTTI will not be commenting further while legal proceedings are underway.

Molecular Targeting Technologies, Inc. (MTTI). MTTI is a clinical stage biotech company developing the Albumin-Binding Evans blue (EB) targeted radiotherapeutic (EB-TRT). MTTI is committed to building value by translating innovative EB-TRT to improve human healthcare. For more information:www.mtarget.com. Contact: Chris Pak, Email: [email protected].

View source version on businesswire.com:https://www.businesswire.com/news/home/20251013226693/en/

Chris Pak, Email: [email protected]

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH LEGAL OTHER SCIENCE GENERAL HEALTH RESEARCH SCIENCE

SOURCE: Molecular Targeting Technologies, Inc.

Copyright Business Wire 2025.

PUB: 10/10/2025 07:27 PM/DISC: 10/10/2025 07:26 PM

http://www.businesswire.com/news/home/20251013226693/en

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • Rich Valdés America at Night
     
    It’s new talk for a new generation, introducing Rich Valdés America at Night!   >>
     
  • The Charlie Kirk Show
    12:00AM - 1:30AM
     
    Charlie Kirk is the next big thing in conservative talk radio and he's now   >>
     
  • The Scott Jennings Show
     
    Jennings is battle-tested on cable news, a veteran of four presidential   >>
     
  • The Mike Gallagher Show
    3:00AM - 6:00AM
     
    Mike Gallagher is one of the most listened-to radio talk show hosts in America.   >>
     

See the Full Program Guide